AdaptHealth Corp. (AHCO)
| Market Cap | 1.80B |
| Revenue (ttm) | 3.24B |
| Net Income (ttm) | -70.79M |
| Shares Out | 135.91M |
| EPS (ttm) | -0.52 |
| PE Ratio | n/a |
| Forward PE | 13.18 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 394,994 |
| Open | 13.09 |
| Previous Close | 13.08 |
| Day's Range | 13.09 - 13.34 |
| 52-Week Range | 7.91 - 13.33 |
| Beta | 1.50 |
| Analysts | Strong Buy |
| Price Target | 13.50 (+1.89%) |
| Earnings Date | May 5, 2026 |
About AHCO
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy... [Read more]
Financial Performance
Financial StatementsAnalyst Forecast
According to 4 analysts, the average rating for AHCO stock is "Strong Buy." The 12-month stock price target is $13.5, which is an increase of 1.89% from the latest price.
News
AdaptHealth Corp. Announces First Quarter 2026 Earnings Release Date and Conference Call
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Announces Refinancing of Senior Secured Credit Facility Resulting in Extended Maturity, Reduced Cost of Debt, and Enhanced Financial Flexibility
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Transcript: Leerink Global Healthcare Conference 2026
Major operational streamlining and technology investments have driven record setup times and census growth across core segments. Exclusive capitated contracts with major payers like Kaiser and Humana are fueling expansion, while divestitures and M&A refine the portfolio. Regulatory changes and payer mix shifts continue to shape strategy.
AdaptHealth Transcript: J.P. Morgan 2026 Global Leveraged Finance Conference
The company is expanding its market share in sleep and respiratory care, leveraging technology and operational improvements to drive high adherence and patient satisfaction. Major contracts with Humana and Kaiser are fueling geographic growth, especially on the West Coast, while regulatory changes and industry consolidation present further opportunities.
HALPER SADEH LLC ENCOURAGES ADAPTHEALTH CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is invest...
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Earnings Call Transcript: Q4 2025
2025 saw record patient census, strong operational improvements, and the launch of the largest industry capitated contract, driving revenue and margin growth. Guidance for 2026 anticipates 6–8% revenue growth, margin expansion, and continued debt reduction, supported by technology and strategic acquisitions.
AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2025 Results and Provides 2026 Financial Guidance
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Announces Upgraded Moody's Ratings
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. to Participate in Upcoming Investor Conference
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Announces Upgraded S&P Global Issue-Level Rating on Senior Unsecured Debt
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Transcript: UBS Global Healthcare Conference 2025
Capitated contracts are expanding, with a new $1B IDN deal and Humana renewal driving predictable revenue. Operational improvements and tech investments are boosting efficiency, while industry consolidation and steady reimbursement rates position the company for strong organic growth.
AdaptHealth Earnings Call Transcript: Q3 2025
Q3 2025 delivered strong organic growth, record patient census in key segments, and improved profitability, driven by operational enhancements and new exclusive capitated contracts. Debt reduction and investments in technology and infrastructure position the company for accelerated growth in 2026.
AdaptHealth Corp. Announces Third Quarter 2025 Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
Halper Sadeh LLC Encourages AdaptHealth Corp. Shareholders to Contact the Firm to Discuss Their Rights
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of AdaptHealth Corp. (NASDAQ: AHCO) breached their fiduciary duties to...
AdaptHealth Corp. Announces Third Quarter 2025 Earnings Release Date and Conference Call
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Transcript: Jefferies 2025 Healthcare Services Conference
Record growth in sleep apnea and operational improvements in diabetes are driving performance, while new large contracts and industry consolidation position the business for further margin expansion. Automation and AI investments are expected to yield significant cost savings, with free cash flow and debt reduction remaining top priorities.
AdaptHealth Transcript: Canaccord Genuity’s 45th Annual Growth Conference
Management restructuring and tech investments drove operational improvements and financial stability. A major five-year, $1 billion contract will expand reach and add new revenue streams, while diabetes and sleep segments show renewed growth.
AdaptHealth Earnings Call Transcript: Q2 2025
Q2 2025 saw stable revenue and strong free cash flow, with a major five-year capitation contract set to drive future growth. Segment performance was mixed, but momentum is building, especially in sleep and diabetes health. Net leverage improved, and guidance for 2025 was reaffirmed.
AdaptHealth Corp. Announces Second Quarter 2025 Results
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Partners With a Major National Healthcare System to Become the Exclusive Provider of Home Medical Equipment
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Corp. Announces Second Quarter 2025 Earnings Release Date and Conference Call
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home ...
AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medi...
AdaptHealth Transcript: RBC Capital Markets Global Healthcare Conference 2025
Diabetes and sleep segments are showing operational improvements, with enhanced retention and new patient growth. Capitated business is expanding, industry consolidation is accelerating, and portfolio optimization is reducing debt and focusing on core segments.